0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostic Biomarker Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-9W6316
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Diagnostic Biomarker Market Insights and Forecast to 2028
BUY CHAPTERS

Global Diagnostic Biomarker Market Research Report 2025

Code: QYRE-Auto-9W6316
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diagnostic Biomarker Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Diagnostic Biomarker Market

Diagnostic Biomarker Market

The global market for Diagnostic Biomarker was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarker.
The Diagnostic Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Diagnostic Biomarker Market Report

Report Metric Details
Report Name Diagnostic Biomarker Market
CAGR 5%
Segment by Type
  • S100
  • MART-1
  • Gp100
  • HMB45
  • AFP
  • BCR-ABL
  • Others
Segment by Application
  • Hospitals
  • Cancer Research Institutes
  • Diagnostic Labs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biocrates Life Sciences, Augurex Life Sciences, Biomedical, Target Discovery, Banyan Biomarkers, Astute Medical, Axela
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Diagnostic Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Diagnostic Biomarker Market report?

Ans: The main players in the Diagnostic Biomarker Market are Biocrates Life Sciences, Augurex Life Sciences, Biomedical, Target Discovery, Banyan Biomarkers, Astute Medical, Axela

What are the Application segmentation covered in the Diagnostic Biomarker Market report?

Ans: The Applications covered in the Diagnostic Biomarker Market report are Hospitals, Cancer Research Institutes, Diagnostic Labs

What are the Type segmentation covered in the Diagnostic Biomarker Market report?

Ans: The Types covered in the Diagnostic Biomarker Market report are S100, MART-1, Gp100, HMB45, AFP, BCR-ABL, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 S100
1.2.3 MART-1
1.2.4 Gp100
1.2.5 HMB45
1.2.6 AFP
1.2.7 BCR-ABL
1.2.8 Others
1.3 Market by Application
1.3.1 Global Diagnostic Biomarker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Biomarker Market Perspective (2020-2031)
2.2 Global Diagnostic Biomarker Growth Trends by Region
2.2.1 Global Diagnostic Biomarker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diagnostic Biomarker Historic Market Size by Region (2020-2025)
2.2.3 Diagnostic Biomarker Forecasted Market Size by Region (2026-2031)
2.3 Diagnostic Biomarker Market Dynamics
2.3.1 Diagnostic Biomarker Industry Trends
2.3.2 Diagnostic Biomarker Market Drivers
2.3.3 Diagnostic Biomarker Market Challenges
2.3.4 Diagnostic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Biomarker Players by Revenue
3.1.1 Global Top Diagnostic Biomarker Players by Revenue (2020-2025)
3.1.2 Global Diagnostic Biomarker Revenue Market Share by Players (2020-2025)
3.2 Global Diagnostic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diagnostic Biomarker Revenue
3.4 Global Diagnostic Biomarker Market Concentration Ratio
3.4.1 Global Diagnostic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarker Revenue in 2024
3.5 Global Key Players of Diagnostic Biomarker Head office and Area Served
3.6 Global Key Players of Diagnostic Biomarker, Product and Application
3.7 Global Key Players of Diagnostic Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Biomarker Breakdown Data by Type
4.1 Global Diagnostic Biomarker Historic Market Size by Type (2020-2025)
4.2 Global Diagnostic Biomarker Forecasted Market Size by Type (2026-2031)
5 Diagnostic Biomarker Breakdown Data by Application
5.1 Global Diagnostic Biomarker Historic Market Size by Application (2020-2025)
5.2 Global Diagnostic Biomarker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diagnostic Biomarker Market Size (2020-2031)
6.2 North America Diagnostic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diagnostic Biomarker Market Size by Country (2020-2025)
6.4 North America Diagnostic Biomarker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Biomarker Market Size (2020-2031)
7.2 Europe Diagnostic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diagnostic Biomarker Market Size by Country (2020-2025)
7.4 Europe Diagnostic Biomarker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Biomarker Market Size (2020-2031)
8.2 Asia-Pacific Diagnostic Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diagnostic Biomarker Market Size by Region (2020-2025)
8.4 Asia-Pacific Diagnostic Biomarker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Biomarker Market Size (2020-2031)
9.2 Latin America Diagnostic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diagnostic Biomarker Market Size by Country (2020-2025)
9.4 Latin America Diagnostic Biomarker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Biomarker Market Size (2020-2031)
10.2 Middle East & Africa Diagnostic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diagnostic Biomarker Market Size by Country (2020-2025)
10.4 Middle East & Africa Diagnostic Biomarker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Details
11.1.2 Biocrates Life Sciences Business Overview
11.1.3 Biocrates Life Sciences Diagnostic Biomarker Introduction
11.1.4 Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2020-2025)
11.1.5 Biocrates Life Sciences Recent Development
11.2 Augurex Life Sciences
11.2.1 Augurex Life Sciences Company Details
11.2.2 Augurex Life Sciences Business Overview
11.2.3 Augurex Life Sciences Diagnostic Biomarker Introduction
11.2.4 Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2020-2025)
11.2.5 Augurex Life Sciences Recent Development
11.3 Biomedical
11.3.1 Biomedical Company Details
11.3.2 Biomedical Business Overview
11.3.3 Biomedical Diagnostic Biomarker Introduction
11.3.4 Biomedical Revenue in Diagnostic Biomarker Business (2020-2025)
11.3.5 Biomedical Recent Development
11.4 Target Discovery
11.4.1 Target Discovery Company Details
11.4.2 Target Discovery Business Overview
11.4.3 Target Discovery Diagnostic Biomarker Introduction
11.4.4 Target Discovery Revenue in Diagnostic Biomarker Business (2020-2025)
11.4.5 Target Discovery Recent Development
11.5 Banyan Biomarkers
11.5.1 Banyan Biomarkers Company Details
11.5.2 Banyan Biomarkers Business Overview
11.5.3 Banyan Biomarkers Diagnostic Biomarker Introduction
11.5.4 Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2020-2025)
11.5.5 Banyan Biomarkers Recent Development
11.6 Astute Medical
11.6.1 Astute Medical Company Details
11.6.2 Astute Medical Business Overview
11.6.3 Astute Medical Diagnostic Biomarker Introduction
11.6.4 Astute Medical Revenue in Diagnostic Biomarker Business (2020-2025)
11.6.5 Astute Medical Recent Development
11.7 Axela
11.7.1 Axela Company Details
11.7.2 Axela Business Overview
11.7.3 Axela Diagnostic Biomarker Introduction
11.7.4 Axela Revenue in Diagnostic Biomarker Business (2020-2025)
11.7.5 Axela Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Diagnostic Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of S100
 Table 3. Key Players of MART-1
 Table 4. Key Players of Gp100
 Table 5. Key Players of HMB45
 Table 6. Key Players of AFP
 Table 7. Key Players of BCR-ABL
 Table 8. Key Players of Others
 Table 9. Global Diagnostic Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Diagnostic Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Diagnostic Biomarker Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Diagnostic Biomarker Market Share by Region (2020-2025)
 Table 13. Global Diagnostic Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Diagnostic Biomarker Market Share by Region (2026-2031)
 Table 15. Diagnostic Biomarker Market Trends
 Table 16. Diagnostic Biomarker Market Drivers
 Table 17. Diagnostic Biomarker Market Challenges
 Table 18. Diagnostic Biomarker Market Restraints
 Table 19. Global Diagnostic Biomarker Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Diagnostic Biomarker Market Share by Players (2020-2025)
 Table 21. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarker as of 2024)
 Table 22. Ranking of Global Top Diagnostic Biomarker Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Diagnostic Biomarker Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Diagnostic Biomarker, Headquarters and Area Served
 Table 25. Global Key Players of Diagnostic Biomarker, Product and Application
 Table 26. Global Key Players of Diagnostic Biomarker, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Diagnostic Biomarker Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Diagnostic Biomarker Revenue Market Share by Type (2020-2025)
 Table 30. Global Diagnostic Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Diagnostic Biomarker Revenue Market Share by Type (2026-2031)
 Table 32. Global Diagnostic Biomarker Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Diagnostic Biomarker Revenue Market Share by Application (2020-2025)
 Table 34. Global Diagnostic Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Diagnostic Biomarker Revenue Market Share by Application (2026-2031)
 Table 36. North America Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Diagnostic Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Diagnostic Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Diagnostic Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Diagnostic Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Diagnostic Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Diagnostic Biomarker Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Diagnostic Biomarker Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Diagnostic Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Diagnostic Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Diagnostic Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Diagnostic Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Biocrates Life Sciences Company Details
 Table 52. Biocrates Life Sciences Business Overview
 Table 53. Biocrates Life Sciences Diagnostic Biomarker Product
 Table 54. Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2020-2025) & (US$ Million)
 Table 55. Biocrates Life Sciences Recent Development
 Table 56. Augurex Life Sciences Company Details
 Table 57. Augurex Life Sciences Business Overview
 Table 58. Augurex Life Sciences Diagnostic Biomarker Product
 Table 59. Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2020-2025) & (US$ Million)
 Table 60. Augurex Life Sciences Recent Development
 Table 61. Biomedical Company Details
 Table 62. Biomedical Business Overview
 Table 63. Biomedical Diagnostic Biomarker Product
 Table 64. Biomedical Revenue in Diagnostic Biomarker Business (2020-2025) & (US$ Million)
 Table 65. Biomedical Recent Development
 Table 66. Target Discovery Company Details
 Table 67. Target Discovery Business Overview
 Table 68. Target Discovery Diagnostic Biomarker Product
 Table 69. Target Discovery Revenue in Diagnostic Biomarker Business (2020-2025) & (US$ Million)
 Table 70. Target Discovery Recent Development
 Table 71. Banyan Biomarkers Company Details
 Table 72. Banyan Biomarkers Business Overview
 Table 73. Banyan Biomarkers Diagnostic Biomarker Product
 Table 74. Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2020-2025) & (US$ Million)
 Table 75. Banyan Biomarkers Recent Development
 Table 76. Astute Medical Company Details
 Table 77. Astute Medical Business Overview
 Table 78. Astute Medical Diagnostic Biomarker Product
 Table 79. Astute Medical Revenue in Diagnostic Biomarker Business (2020-2025) & (US$ Million)
 Table 80. Astute Medical Recent Development
 Table 81. Axela Company Details
 Table 82. Axela Business Overview
 Table 83. Axela Diagnostic Biomarker Product
 Table 84. Axela Revenue in Diagnostic Biomarker Business (2020-2025) & (US$ Million)
 Table 85. Axela Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Diagnostic Biomarker Picture
 Figure 2. Global Diagnostic Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diagnostic Biomarker Market Share by Type: 2024 VS 2031
 Figure 4. S100 Features
 Figure 5. MART-1 Features
 Figure 6. Gp100 Features
 Figure 7. HMB45 Features
 Figure 8. AFP Features
 Figure 9. BCR-ABL Features
 Figure 10. Others Features
 Figure 11. Global Diagnostic Biomarker Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Diagnostic Biomarker Market Share by Application: 2024 VS 2031
 Figure 13. Hospitals Case Studies
 Figure 14. Cancer Research Institutes Case Studies
 Figure 15. Diagnostic Labs Case Studies
 Figure 16. Diagnostic Biomarker Report Years Considered
 Figure 17. Global Diagnostic Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Diagnostic Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Diagnostic Biomarker Market Share by Region: 2024 VS 2031
 Figure 20. Global Diagnostic Biomarker Market Share by Players in 2024
 Figure 21. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarker as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Diagnostic Biomarker Revenue in 2024
 Figure 23. North America Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Diagnostic Biomarker Market Share by Country (2020-2031)
 Figure 25. United States Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Diagnostic Biomarker Market Share by Country (2020-2031)
 Figure 29. Germany Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Diagnostic Biomarker Market Share by Region (2020-2031)
 Figure 37. China Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Diagnostic Biomarker Market Share by Country (2020-2031)
 Figure 45. Mexico Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Diagnostic Biomarker Market Share by Country (2020-2031)
 Figure 49. Turkey Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Diagnostic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Biocrates Life Sciences Revenue Growth Rate in Diagnostic Biomarker Business (2020-2025)
 Figure 53. Augurex Life Sciences Revenue Growth Rate in Diagnostic Biomarker Business (2020-2025)
 Figure 54. Biomedical Revenue Growth Rate in Diagnostic Biomarker Business (2020-2025)
 Figure 55. Target Discovery Revenue Growth Rate in Diagnostic Biomarker Business (2020-2025)
 Figure 56. Banyan Biomarkers Revenue Growth Rate in Diagnostic Biomarker Business (2020-2025)
 Figure 57. Astute Medical Revenue Growth Rate in Diagnostic Biomarker Business (2020-2025)
 Figure 58. Axela Revenue Growth Rate in Diagnostic Biomarker Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD